Clinical Trials Directory

Trials / Completed

CompletedNCT01164644

The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
18 Years – 89 Years
Healthy volunteers
Not accepted

Summary

Arnica montana is a homeopathic drug that is made in accordance with the official methods of the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic surgeons throughout the world, although there is no study proving its benefit after rhinoplasty surgery. The purpose of the research is to see if Arnica montana will reduce the amount of bruising and the intensity of the bruising after surgery. Photographs of the subject's face will be taken and used to analyze bruising after rhinoplasty surgery in subjects who receive Arnica montana and compare them to photographs of subjects who take a placebo (sugar pill).

Detailed description

Subjects will receive either oral arnica montana or placebo without any identifying labels or markers on the drugs. During the post-operative period, the patients will be seen back in surgery clinic on post-operative days 3, 7 and 10. During the first two visits, the subject will receive routine post-operative care with no difference from patients not enrolled in the study. This includes routine sets of photographs. The participant will then return for a third post-operative visit lasting under ten minutes only for study photos using the left and right "three-quarters" view. Again, the subject will hold a measurement marker so length measurements can be made, and this marker will be held under the ear to not interfere with the routine cosmetic analysis of the photographs. The digital photographs will be used to analyze the bruising for the study. The ratio was calculated by dividing the number of pixels of bruised area over number of pixels of standard area.

Conditions

Interventions

TypeNameDescription
DRUGArnica montanaSubjects will take twelve pills by mouth three times a day over four days.
DRUGPlaceboSubjects will take twelve pills by mouth three times a day over four days.

Timeline

Start date
2010-06-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2010-07-16
Last updated
2017-05-17
Results posted
2013-05-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01164644. Inclusion in this directory is not an endorsement.